Not Tagged
Not Tagged
['sclc', 'nsclc', 'hodgkin', 'lymphoma']
an exciting weekend is ahead at #asco22! this is such a special time for scientific exchange. we re looking forward to posters for our pd-l1 &amp; egfr inhibitors in nsclc &amp; an oral presentation for our pd-l1 inhibitor in a rare form of non-hodgkin lymphoma: 
Co-founder & CEO @EQRxInc | Committed to making innovative medicines at dramatically lower prices for the benefit of people and society.